Log In
Print this Print this

Abreva, docosanol

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
Description10% n-docosanol antiviral cream
Molecular Target Not available
Mechanism of ActionCell membrane destabilization
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat cold sores
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today